PINZI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 3.957
AS - Asia 2.284
EU - Europa 2.025
SA - Sud America 424
AF - Africa 43
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.738
Nazione #
US - Stati Uniti d'America 3.881
IT - Italia 891
SG - Singapore 762
CN - Cina 646
HK - Hong Kong 374
BR - Brasile 344
GB - Regno Unito 325
SE - Svezia 254
VN - Vietnam 191
DE - Germania 113
RU - Federazione Russa 104
ID - Indonesia 87
FI - Finlandia 47
KR - Corea 47
CA - Canada 42
NL - Olanda 42
IN - India 40
AR - Argentina 35
LT - Lituania 35
UA - Ucraina 35
BG - Bulgaria 32
TR - Turchia 29
BD - Bangladesh 25
ES - Italia 25
FR - Francia 24
MX - Messico 23
BE - Belgio 18
PL - Polonia 18
AT - Austria 15
EC - Ecuador 15
ZA - Sudafrica 15
JP - Giappone 14
IE - Irlanda 13
IQ - Iraq 13
IR - Iran 12
VE - Venezuela 10
CO - Colombia 8
EG - Egitto 7
IL - Israele 6
UZ - Uzbekistan 6
CH - Svizzera 5
GR - Grecia 5
KE - Kenya 5
PK - Pakistan 5
RO - Romania 5
HR - Croazia 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
LK - Sri Lanka 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NR - Nauru 1
OM - Oman 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 8.738
Città #
Santa Clara 618
Fairfield 406
Singapore 391
Ashburn 385
Hong Kong 365
Chandler 288
Hefei 228
Nyköping 182
Woodbridge 170
Modena 158
Seattle 139
London 134
Houston 132
Cambridge 120
Beijing 117
Wilmington 112
Southend 109
Milan 96
Bologna 91
Ann Arbor 88
Los Angeles 85
Ho Chi Minh City 75
Jakarta 74
Chicago 64
New York 58
Seoul 44
Hanoi 43
San Diego 43
Princeton 41
Dearborn 38
Shanghai 36
The Dalles 36
Jacksonville 34
Reggio Emilia 34
Sofia 31
Helsinki 30
Parma 30
São Paulo 30
Rome 29
Salt Lake City 28
Buffalo 26
Munich 25
Dallas 23
Council Bluffs 19
Moscow 19
Tampa 19
Brussels 18
Elk Grove Village 18
Nuremberg 16
Warsaw 16
Eugene 15
Toronto 15
Kent 14
Poplar 14
Rio de Janeiro 14
Denver 13
Formigine 13
Redondo Beach 13
Stockholm 12
Tokyo 12
Chennai 11
Orem 11
Phoenix 11
Guangzhou 10
Haiphong 10
Izmir 10
Johannesburg 10
Kilburn 10
Lappeenranta 10
Des Moines 9
Frattamaggiore 9
Mexico City 9
Montreal 9
Vienna 9
Bari 8
Boston 8
Brooklyn 8
Dublin 8
Frankfurt am Main 8
Meana Sardo 8
Paris 8
Redwood City 8
Atlanta 7
Biên Hòa 7
Boardman 7
Brasília 7
Brescia 7
Mumbai 7
Naples 7
Ottawa 7
Turin 7
Curitiba 6
Dhaka 6
Hangzhou 6
Manchester 6
Perugia 6
San Cesario sul Panaro 6
Afragola 5
Amsterdam 5
Ankara 5
Totale 5.862
Nome #
An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators 320
On the integration of in silico drug design methods for drug repurposing 279
Selection of protein conformations for structure-based polypharmacology studies 278
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 251
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 248
Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank 247
Identification of small-molecule EGFR allosteric inhibitors by high-Throughput docking 241
Identification of 4-aryl-1H-pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors 237
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 237
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease 231
Computational polypharmacology comes of age 225
Molecular docking: Shifting paradigms in drug discovery 221
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 219
Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L. 213
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 208
Design of dual inhibitors of histone deacetylase 6 and heat shock protein 90 205
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models 205
LigAdvisor: A versatile and user-friendly web-platform for drug design 188
2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B 186
Dual Targeting Strategies On Histone Deacetylase 6 (HDAC6) And Heat Shock Protein 90 (Hsp90) 181
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 172
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies 165
Refinement and rescoring of virtual screening results 162
In silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (ACP) reductase (INHA) 159
Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies 154
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing 151
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications 148
How drug repurposing can advance drug discovery: challenges and opportunities 145
Repositioning natural products in drug discovery 145
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors 141
Virtual screening for dual Hsp90/B-Raf inhibitors 139
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 138
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring 135
Development of machine learning classifers to predict compound activity on prostate cancer cell lines. 131
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 129
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity 128
Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers 122
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B 119
Development and application of LigAdvisor, a user-friendly web-platform for polypharmacology and drug repurposing 117
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR 115
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase 115
On the development of B-Raf inhibitors acting through innovative mechanisms 105
LigAdvisor: a web server to perform in silico explorations on crystallographic ligands and known drugs for polypharmacology and drug repurposing. 100
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines 99
LigAdvisor: a web platform designed for charting novel polypharmacology and drug repurposing routes from crystallographic ligands and known drugs 98
Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction 97
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 91
Targeting the allosteric sites of the B-Raf protein kinase through an in silico approach 90
Tackling polypharmacology and drug repurposing with the LigAdvisor webserver. 83
Rational design of dual inhibitors of Hsp90 and B-Raf as a novel pharmacological approach against melanomas 82
Exploring Biological Targets of Magnolol and Honokiol and their Nature-Inspired Synthetic Derivatives: In Silico Identification and Experimental Validation of Estrogen Receptors 79
Unveiling target associations for polypharmacology from analysis of crystallographic ligands in the Protein Data Bank 77
Rational design of dual inhibitors of Hsp90 and Braf as a novel pharmacological approach against melanomas 74
Trends and Applications in Computationally Driven Drug Repurposing 72
Polypharmacology predictions in the Protein Data Bank 71
Predicting drug polypharmacology using structural databases 68
Totale 8.836
Categoria #
all - tutte 41.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021574 0 0 0 0 0 101 111 75 65 81 73 68
2021/2022807 67 41 48 52 19 36 49 61 88 54 192 100
2022/2023905 105 129 70 84 87 107 37 96 107 27 39 17
2023/2024793 29 44 54 79 138 61 102 111 17 14 49 95
2024/20252.554 64 19 67 188 490 314 134 185 220 286 264 323
2025/20262.196 296 188 355 560 602 195 0 0 0 0 0 0
Totale 8.836